A patient's blood T cells are genetically modified to express receptor molecules to detect and eradicate cancer cells. In the top figure, T cells are engineered to express the chimeric antigen receptor (CAR); in the bottom figure the T cell receptor (TCR).
![](https://cdn.myportfolio.com/549eb7057ea186c18acb67464e86ab70/53d1a818-091f-4f10-95ce-2c3265c42189_rw_1200.jpg?h=491fc2a116da113bfcfcbe2a788ad830)
![](https://cdn.myportfolio.com/549eb7057ea186c18acb67464e86ab70/81833eab-e6a5-4d7c-a22a-c91c20ec4d01_rw_1200.jpg?h=884d5ebd770fb44d6aad4af26a12239e)
Client: Kite Pharma, Inc., Santa Monica (CA, USA)